Early Treatment of High-Risk Smoldering Multiple Myeloma Improves Outcomes

Early treatment with lenalidomide and dexamethasone in patients with high-risk smoldering myeloma significantly delayed progression to symptomatic disease and prolonged survival with a good safety profile.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news